Schizophrenia

Predictors of response in a sample of treatment-resistant psychotic patients on clozapine.

Ciapparelli A, Ducci F, Carmassi C, Carlini M, Paggini R, Catena M, et al. Predictors of response in a sample of treatment-resistant psychotic patients on clozapine. Eur Arch Psychiatry Clin Neurosci. 2004;254(5):343-6. DOI: 10.1007/s00406-004-0511-4. PubMed PMID: 15365711.

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.

Masellis M, Basile VS, Ozdemir V, Meltzer HY, Macciardi FM, Kennedy JL. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine. Biol Psychiatry. 2000;47(3):252-66. PubMed PMID: 10682223.

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, et al. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology. 1998;19(2):123-32. DOI: 10.1016/S0893-133X(98)00007-4. PubMed PMID: 9629566.

Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine.

Malhotra AK, Goldman D, Ozaki N, Breier A, Buchanan R, Pickar D. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatry. 1996;153(8):1092-4. DOI: 10.1176/ajp.153.8.1092. PubMed PMID: 8678181.

No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response.

Bolonna AA, Arranz MJ, Munro J, Osborne S, Petouni M, Martinez M, et al. No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response. Neurosci Lett. 2000;280(1):65-8. PubMed PMID: 10696813.

Genetic predictors of therapeutic response to clozapine: current status of research.

Mancama D, Arranz MJ, Kerwin RW. Genetic predictors of therapeutic response to clozapine: current status of research. CNS Drugs. 2002;16(5):317-24. PubMed PMID: 11994021.

Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy.

Chow V, Reddel C, Pennings G, Scott E, Pasqualon T, Ng ACC, et al. Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy. Schizophr Res. 2015;162(1-3):175-82. DOI: 10.1016/j.schres.2014.12.042. PubMed PMID: 25634682.

Reduced integrity of the left arcuate fasciculus is specifically associated with auditory verbal hallucinations in schizophrenia.

McCarthy-Jones S, Oestreich LKL, Whitford TJ. Reduced integrity of the left arcuate fasciculus is specifically associated with auditory verbal hallucinations in schizophrenia. Schizophr Res. 2015;162(1-3):1-6. DOI: 10.1016/j.schres.2014.12.041. PubMed PMID: 25631452.

Is good insight associated with depression among patients with schizophrenia? Systematic review and meta-analysis.

Belvederi Murri M, Respino M, Innamorati M, Cervetti A, Calcagno P, Pompili M, et al. Is good insight associated with depression among patients with schizophrenia? Systematic review and meta-analysis. Schizophr Res. 2015;162(1-3):234-47. DOI: 10.1016/j.schres.2015.01.003. PubMed PMID: 25631453.

Compensatory cognitive training for people with first-episode schizophrenia: results from a pilot randomized controlled trial.

Mendella PD, Burton CZ, Tasca GA, Roy P, St Louis L, Twamley EW. Compensatory cognitive training for people with first-episode schizophrenia: results from a pilot randomized controlled trial. Schizophr Res. 2015;162(1-3):108-11. DOI: 10.1016/j.schres.2015.01.016. PubMed PMID: 25631454.